fropenem has been researched along with Bacterial Disease in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.67) | 18.2507 |
2000's | 13 (86.67) | 29.6817 |
2010's | 1 (6.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, SD; Critchley, IA; Janjic, N; Tillotson, GS; Traczewski, MM | 1 |
Gandra, S; Klein, EY; Laxminarayan, R; Malhotra-Kumar, S; Pant, S | 1 |
Fluit, AC; Milatovic, D; Schmitz, FJ; Verhoef, J | 1 |
Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA | 1 |
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
Blandino, G; Caccamo, F; Milazzo, I; Musumeci, R; Nicoletti, G; Speciale, A | 1 |
Alefelder, M; Arvis, P; Berg, O; Gehanno, P; Leiberman, A; Martinkenas, JL; Nikolaidis, P; Reimnitz, P; Siegert, R | 1 |
Johnson, MM; Piddock, LJ; Webber, MA | 1 |
Behra-Miellet, J; Bryskier, A; Dubreuil, L | 1 |
Echols, R; Kowalsky, S; Rosemore, M; Tosiello, R; Upchurch, J | 1 |
Echols, RM; Hadley, JA; Tillotson, GS; Tosiello, R | 1 |
Hoban, DJ; Karlowsky, JA; Rubinstein, E; Schurek, KN; Wiebe, R; Zhanel, GG | 1 |
Crank, CW; Gettig, JP; Philbrick, AH | 1 |
Akatsuka, K; Chimura, T; Funayama, T; Hayashi, Y; Hirayama, T; Kaneko, N; Morisaki, N; Murayama, K; Numazaki, M; Oda, T; Sato, F | 1 |
4 review(s) available for fropenem and Bacterial Disease
Article | Year |
---|---|
Faropenem medoxomil: a treatment option in acute bacterial rhinosinusitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Sinusitis; Streptococcus pneumoniae; United States | 2006 |
Faropenem: review of a new oral penem.
Topics: Administration, Oral; Animals; Bacterial Infections; beta-Lactams; Humans | 2007 |
Faropenem medoxomil.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic; Time Factors | 2008 |
Faropenem medoxomil: A0026, BAY 56-6854, BAY 566854, faropenem daloxate, SUN 208, SUN A0026.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Drug Interactions; Humans; Prodrugs | 2008 |
3 trial(s) available for fropenem and Bacterial Disease
Article | Year |
---|---|
Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefuroxime; Double-Blind Method; Female; Humans; Lactams; Male; Maxillary Sinusitis; Middle Aged; Prospective Studies; Treatment Outcome | 2003 |
Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefuroxime; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prospective Studies; Sinusitis; Time Factors | 2006 |
[Clinical studies of faropenem in the field of obstetrics and gynecology].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cystitis; Female; Genital Diseases, Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Lactams; Mastitis; Middle Aged; Pelvic Inflammatory Disease; Uterine Cervicitis; Uterine Diseases | 1999 |
8 other study(ies) available for fropenem and Bacterial Disease
Article | Year |
---|---|
National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Geography; Haemophilus influenzae; Health Surveys; Humans; Moraxella catarrhalis; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2007 |
Faropenem Consumption is Increasing in India.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Resistance, Multiple; Drug Utilization; Humans; India; Microbial Sensitivity Tests | 2016 |
In vitro activity of faropenem against 5460 clinical bacterial isolates from Europe.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Europe; Humans; Lactams; Microbial Sensitivity Tests | 2002 |
Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Bites and Stings; Fluoroquinolones; Humans; Lactams; Macrolides; Skin Diseases, Bacterial; Tetracyclines | 2002 |
Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroidaceae Infections; beta-Lactams; Cefepime; Cefmetazole; Cefoperazone; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mouth Diseases; Penicillin G; Penicillins; Peptostreptococcus; Porphyromonas gingivalis; Prevotella; Streptococcal Infections; Streptococcus; Sulbactam | 2002 |
Faropenem, a new oral penem: antibacterial activity against selected anaerobic and fastidious periodontal isolates.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Humans; Lactams; Mouth; Periodontal Diseases | 2003 |
Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins | 2003 |
In vitro evaluation of faropenem activity against anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Humans; In Vitro Techniques; Lactams; Microbial Sensitivity Tests | 2005 |